Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhixun,Zhao

第一单位： Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

作者： Zhixun,Zhao ^[1] ; Yanwei,Yang ^[2] ; Zheng,Liu ^[1] ; Haipeng,Chen ^[1] ; Xu,Guan ^[1] ; Zheng,Jiang ^[1] ; Ming,Yang ^[1] ; Hengchang,Liu ^[1] ; Tianli,Chen ^[1] ; Yibo,Gao ^[3] ; Shuangmei,Zou ^[4] ; Xishan,Wang ^[1]

作者单位： Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[1] Department of Laboratory, National Center for Children's Health/Beijing Children's Hospital, Capital Medical University, Beijing, China. ^[2] Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.;Laboratory of Translational Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.;State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.;Central Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[3] Department of Pathology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[4]

关键词 immune response immunotherapy mannose receptor C type 2 (MRC2)pan-cancer prognosis

DOI 10.3389/fmolb.2022.951636

PMID 36188226

发布时间 2022-10-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2022年9卷

951636页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除